Hospitals split over role drug firms play
Involvement in tests raises concerns over integrity of studies
America's teaching hospitals, the premier institutions for testing the safety of prescription drugs, disagree sharply about how much control over clinical trial results they should cede to drug companies, according to a study published today. (Full article: 703 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
